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The paper by Jie Chang and colleagues published in The Lancet Infectious Diseases is very timely 
(1). This reflects a critical need for concerted efforts to reduce irrational use of antibiotics to lower 
rising antimicrobial resistance (AMR) rates (2-4), with their overuse resulting in antibiotics becoming 
the most commonly used medicines globally (3, 5). AMR increases morbidity, mortality, and costs as 
health systems run out of antimicrobial options to treat common infectious diseases (1, 2, 6, 7). Lower 
and middle-income countries (LMICs) including China are a particular concern given their increasing 
overuse of antibiotics (8) coupled with a greater impact of AMR due to issues including poor 
sanitation, malnutrition and dense populations (8).   
 
A critical issue among LMICs is inappropriate non-prescription antibiotic sales especially for self-
limiting diseases such as diarrhoea and upper respiratory tract infections (URTIs) of viral aetiology (1, 
3-5, 7, 8). Concerns are exacerbated by often shorter courses and inappropriate antibiotics being 
dispensed (3). Overall, rates of non-prescription sales of antibiotics in LMICs are up to 93% of 
dispensed antibiotics, with up to 100% of pharmacists dispensing antibiotics without a prescription in 
some LMICs despite legislation against such practises (1, 4, 5, 8, 9). Ours and others’ experience is 
that non-prescription antibiotic sales is driven by multiple reasons including pressure from patients 
and financial reasons, i.e. profit-motivated community pharmacists fearing losing clients seeking 
antibiotics to competitors and high rates of self-medication where patients cannot afford physician 
fees and opt straight for out-of-pocket purchases. Ease of access to antibiotics and weak enforcement 
of regulations also enhance non-prescription sales. Easier access of community pharmacies as 
opposed to physicians in primary healthcare centres with often medicine shortages, coupled with 
cultural issues and poor levels of education (1, 5, 8), also influences patients’ behaviour.  
 
Consequently, community pharmacists are a critical component to improving the management of 
patients with URTIs and paediatric diarrhoea especially as they are often the first healthcare 
professional patients consult (1, 10). However, there can be concerns with their level of knowledge 
regarding antibiotics, antimicrobial stewardship (AMS), and AMR (1, 11, 12). Initiatives are needed to 
address this. 
 
The comprehensive approach by Chang et al using simulated clients (SCs) provides further insight 
into current rates of non-prescription sales of antibiotics in China where the authorities are seeking to 
change behaviour (1). Using simulated clients helps gain an accurate insight into not only 
pharmacists’ but also other health professionals’ behaviour towards antibiotics (1, 8, 10). Whilst there 
are still concerns with the high rate of non-prescription sales of antibiotics among community 
pharmacists across China at 48.5% and 70.1% for paediatric diarrhoea and URTIs, respectively, and 
only a limited number asked the simulated clients about taking other medicines (6.6% to 9.7%) or 
their allergies and issuing advice on medicine taking (16.1% to 29.2%), there were encouraging signs 
(1). These include the fact that sales were significantly less common in urban areas, having a 
pharmacist on duty and being part of a pharmacy chain (1). In addition, multiple initiatives in Shaanxi 
including stricter regulations for dispensing antibiotics, a qualified pharmacist’s presence to dispense 
antibiotics, increased frequency of unannounced pharmacy inspections, punishments for misuse, and 
improving pharmacists’ education, showed decreasing antibiotic sales between 2011 and 2017 (1).  
 
As a result of the findings of Chang et al and our experience, we believe several strategies can be 
implemented to reduce non-prescription antibiotic sales. These include improving pharmacists’ 
knowledge and practice of AMS starting in pharmacy school coupled with the use of the Internet and 
educational workshops post qualification (1), making pharmacists more aware of the WHO AWaRe 
antibiotic list especially which antibiotics not to dispense, as well as developing and implementing 
national guidelines for pharmacists (1, 4, 13). Other activities including reinforcing legislation where 
pertinent, instigating IT surveillance systems to track antibiotics through the supply chain, monitoring 
pharmacy activities using mobile technologies and increased patient education on the dangers of self-
medication with antibiotics.  Multifaceted programmes are typically needed to change behaviour. 
Notwithstanding that community health campaigns are more challenging in LMICs (14), by 
championing pharmacists as antibiotic guardians they can take the lead to improving antibiotic use in 
the community and reduce AMR rates.  
 
In conclusion, the findings by Chang and colleagues do provide guidance in this crucial area, and we 
will be monitoring developments in the future to reduce AMR rates.  
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